Document is current
Any future updates will be listed below
-
Authors
Kwon, Dong-il
Mao, Tianyang https://orcid.org/0000-0001-9251-8592
Israelow, Benjamin https://orcid.org/0000-0002-1308-8246
Santos Guedes de Sá, Keyla
Dong, Huiping
Iwasaki, Akiko https://orcid.org/0000-0002-7824-9856
-
Funding
Funding for this research was provided by:
Howard Hughes Medical Institute (N/A)
- License Information
-
More Information
Article History
Received: 4 March 2025
Accepted: 8 April 2025
First Online: 13 May 2025
Competing interests
: A.I. co-founded RIGImmune, Xanadu Bio and PanV and is a member of the board of directors of Roche Holding Ltd and Genentech. The other authors declare no competing interests.
